The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment-Reference-Cited by-同舟云学术

The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment

Published:2021-05-12 Issue:12 Volume:10 Page:3873-3885
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Sueoka‐Aragane Naoko¹,Nakashima Chiho¹,Yoshida Hironori²,Matsumoto Naohisa³,Iwanaga Kentaro⁴,Ebi Noriyuki⁵,Nishiyama Akihiro⁶,Yatera Kazuhiro⁷,Kuyama Shoichi⁸,Fukuda Minoru⁹^ORCID,Ushijima Sunao¹⁰,Umeguchi Hitomi¹¹,Harada Daijiro¹²,Kashiwabara Kosuke¹³,Suetsugu Takayuki¹⁴,Fujimoto Nobukazu¹⁵,Tanaka Fumihiro¹⁶,Uramoto Hidetaka¹⁷,Yoshii Chiharu¹⁸,Nakatomi Katsumi¹⁹,Koh Genju²⁰,Seki Nobuhiko²¹,Aoe Keisuke²²,Nosaki Kaname²³,Inoue Koji²⁴,Takamori Ayako²⁵,Kawaguchi Atsushi²⁶

Affiliation:

1. Division of Hematology, Respiratory Medicine and Oncology Department of Internal Medicine Faculty of Medicine Saga University Saga Japan

2. Department of Respiratory Medicine Graduate School of Medicine Kyoto University Kyoto Japan

3. Department of Respiratory Medicine Juntendo University Graduate School of Medicine Tokyo Japan

4. Department of Respiratory medicine Saga‐Ken Medical Centre Koseikan Saga Japan

5. Department of Respiratory Medicine Iizuka Hospital Fukuoka Japan

6. Division of Medical Oncology Cancer Research InstituteKanazawa University Ishikawa Japan

7. Department of Respiratory Medicine University of Occupational and Environmental Health Fukuoka Japan

8. Department of Respiratory Medicine National Hospital Organization Iwakuni Clinical Center Yamaguchi Japan

9. Department of Respiratory Medicine Nagasaki University Hospital Nagasaki Japan

10. Department of Respiratory Medicine Kumamoto Chuo Hospital Kumamoto Japan

11. Department of respiratory medicine Karatsu Red Cross Hospital Saga Japan

12. Department of Thoracic Oncology National Hospital Organization Shikoku Cancer Center Ehime Japan

13. Department of Respiratory Medicine Kumamoto Regional Medical Center Kumamoto Japan

14. Department of Respiratory Medicine Sendai Medical Association Hospital Kagoshima Japan

15. Department of Medical Oncology Okayama Rosai Hospital Okayama Japan

16. Second Department of Surgery University of Occupational and Environmental Health Japan

17. Department of Thoracic Surgery Kanazawa Medical University Ishikawa Japan

18. Department of Respiratory Medicine Wakamatsu Hospital of the University of Occupational and Environmental Health Kitakyushu Japan

19. Department of Respiratory Medicine National Hospital Organization Ureshino Medical Center Saga Japan

20. Department of Medical Oncology Yao Tokushukai General Hospital Osaka Japan

21. Division of Medical Oncology Department of Internal Medicine Teikyo University School of Medicine Tokyo Japan

22. Department of Medical Oncology and Clinical Research National Hospital Organization Yamaguchi‐Ube Medical Center Yamaguchi Japan

23. Department of Thoracic Oncology National Hospital Organization Kyushu Cancer Center Fukuoka Japan

24. Department of Respiratory Medicine Ehime Prefectural Central Hospital Ehime Japan

25. Clinical Research Center Saga University Hospital Saga Japan

26. Education and Research Center for Community Medicine Faculty of Medicine Saga University Saga Japan

Funder

AstraZeneca

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3929

Reference31 articles.

1. Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

2. Detecting cancer by monitoring circulating tumor DNA

3. Tracking the Evolution of Non–Small-Cell Lung Cancer

4. Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study

5. Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid biopsy for the management of NSCLC patients under osimertinib treatment;Critical Reviews in Clinical Laboratory Sciences;2024-02-02

2. Saturation resistance profiling of EGFR variants against tyrosine kinase inhibitors using prime editing;2023-12-05

3. Harnessing liquid biopsies: Exosomes and ctDNA as minimally invasive biomarkers for precision cancer medicine;The Journal of Liquid Biopsy;2023-12

4. THE ROLE OF NEXT-GENERATION SEQUENCING IN LUNG CANCER DIAGNOSIS;Eastern Ukrainian Medical Journal;2023

5. Evaluation of Clinical Outcomes of Icotinib in Patients With Clinically Diagnosed Advanced Lung Cancer With EGFR-Sensitizing Variants Assessed by Circulating Tumor DNA Testing;JAMA Oncology;2022-09-01